- Home
- FNLC vs LFCR Comparison
FNLC vs LFCR Comparison
Compare FNLC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNLC | LFCR |
|---|---|---|
| Founded | 1864 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.9M | 269.8M |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FNLC | LFCR |
|---|---|---|
| Price | $27.70 | $6.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.0K | ★ 100.5K |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.34% | N/A |
| EPS Growth | ★ 26.34 | N/A |
| EPS | ★ 3.07 | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $9.07 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $22.11 | $4.76 |
| 52 Week High | $30.33 | $8.98 |
Technical Indicators
Market Signals| Indicator | FNLC | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 31.54 |
| Support Level | $26.13 | $6.60 |
| Resistance Level | $27.49 | $7.03 |
| Average True Range (ATR) | 0.83 | 0.29 |
| MACD | -0.15 | -0.01 |
| Stochastic Oscillator | 24.17 | 28.57 |
Price Performance
Historical ComparisonAbout FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.